First Time Loading...

Armata Pharmaceuticals Inc
NYSE-MKT:ARMP

Watchlist Manager
Armata Pharmaceuticals Inc Logo
Armata Pharmaceuticals Inc
NYSE-MKT:ARMP
Watchlist
Price: 2.7302 USD 1.12% Market Closed
Updated: Jun 1, 2024
ARMP
/
Cash Flow Statement
/
Cash from Financing Activities

Armata Pharmaceuticals Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Armata Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Armata Pharmaceuticals Inc
NYSE-MKT:ARMP
Cash from Financing Activities
$59.3m
CAGR 3-Years
45%
CAGR 5-Years
65%
CAGR 10-Years
9%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$211m
CAGR 3-Years
74%
CAGR 5-Years
59%
CAGR 10-Years
24%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
-$2.2B
CAGR 3-Years
31%
CAGR 5-Years
33%
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$625m
CAGR 3-Years
2%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.4B
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Armata Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
59.3m USD

Based on the financial report for Mar 31, 2024, Armata Pharmaceuticals Inc's Cash from Financing Activities amounts to 59.3m USD.

What is Armata Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
9%

Over the last year, the Cash from Financing Activities growth was 105%. The average annual Cash from Financing Activities growth rates for Armata Pharmaceuticals Inc have been 45% over the past three years , 65% over the past five years , and 9% over the past ten years .

ALPHA SPREAD
Join more than 142,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.